SD Biotechnologies Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 66

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

  • Investments
  • 3

SD Biotechnologies General Information

Description

SD Biotechnologies Co Ltd business is divided into two divisions: cosmetics and food. The cosmetics division products are Mask packs, patches, basic cosmetics, etc. Food division products are Solid broth, freeze-dried vegetables, etc. Its brands are SNP, SNP Prep, and Five Senses Table. It generates the majority of its revenue from the cosmetics division.

Contact Information

Website
www.sdbiotech.co.kr
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 66, Magokjungang 8-ro 1-gil
  • Gangseo-gu
  • Seoul
  • South Korea
+82
Primary Industry
Personal Products
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Daewon Pharmaceutical
Vertical(s)
Manufacturing, Life Sciences
Former Stock Listing
217480
Corporate Office
  • 66, Magokjungang 8-ro 1-gil
  • Gangseo-gu
  • Seoul
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SD Biotechnologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SD Biotechnologies‘s full profile, request access.

Request a free trial

SD Biotechnologies Patents

  • 23

    Total Documents Applications and Grants

  • Total Patents Families

  • 3

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

SD Biotechnologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022119352-A1 Antitussive and mucoactive composition comprising extract of hibiscus syriacus l. as active ingredient Inactive 03-Dec-2020
WO-2022050819-A1 Composition for anti-inflammation, skin wrinkle reduction and moisturization and skin regeneration promotion, containing, as active ingredient, extract of enzyme-treated krill oil Inactive 07-Sep-2020
WO-2022045638-A1 Composition for improving skin condition containing, as active ingredient, fermented storm petrel nest extract using new strain of genus lactobacillus Inactive 24-Aug-2020
WO-2021149860-A1 Composition for alleviating atopic dermatitis and reducing skin wrinkles, using lactobacillus-fermented thyme extract as effective component Inactive 23-Jan-2020
WO-2021066248-A1 Composition comprising exosome derived from nest of fork-tailed storm-petrel as active ingredient for improving skin condition Inactive 04-Oct-2019 A61K8/981
To view SD Biotechnologies’s complete patent history, request access »

SD Biotechnologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SD Biotechnologies Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore SD Biotechnologies‘s full profile, request access.

Request a free trial

SD Biotechnologies Investments & Acquisitions (3)

SD Biotechnologies’s most recent deal was a Merger/Acquisition with Immunobiotech. The deal was made on 01-Jan-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Immunobiotech 01-Jan-2023 Merger/Acquisition Other Pharmaceuticals and Biotechnology
Immunobiotech 20-Dec-2022 Secondary Transaction - Private Other Pharmaceuticals and Biotechnology
LX Glass (9,362.60 Square Meter Land and 4,728.25 Square Meter Building in Incheon, South Korea) 19-May-2017 Corporate Asset Purchase Buildings and Property
To view SD Biotechnologies’s complete investments and acquisitions history, request access »

SD Biotechnologies Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Immunobiotech Seoul, South Korea 2013

SD Biotechnologies FAQs

  • When was SD Biotechnologies founded?

    SD Biotechnologies was founded in 2008.

  • Where is SD Biotechnologies headquartered?

    SD Biotechnologies is headquartered in Seoul, South Korea.

  • What is the size of SD Biotechnologies?

    SD Biotechnologies has 66 total employees.

  • What industry is SD Biotechnologies in?

    SD Biotechnologies’s primary industry is Personal Products.

  • Is SD Biotechnologies a private or public company?

    SD Biotechnologies is a Private company.

  • What is SD Biotechnologies’s current revenue?

    The current revenue for SD Biotechnologies is .

  • Who are SD Biotechnologies’s investors?

    Nvestor (Korea) and SV Investment have invested in SD Biotechnologies.

  • When was SD Biotechnologies acquired?

    SD Biotechnologies was acquired on 01-Dec-2023.

  • Who acquired SD Biotechnologies?

    SD Biotechnologies was acquired by Daewon Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process